DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Maxalt-MLT (Rizatriptan) - Drug Label Confusion - Suspected Cause - Side Effect Reports


Index of reports > Cases with Drug Label Confusion (1)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Maxalt-MLT (Rizatriptan) where reactions include drug label confusion. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Maxalt-MLT side effects in

Reported by a physician from United States on 2012-08-06


Reactions: Vomiting, Wrong Technique in Drug Usage Process, Throat Irritation, Drug Ineffective, Drug Label Confusion, Abdominal Pain Upper

Drug(s) suspected as cause:
    Dosage: unk mg, unk
    Administration route: Oral
    Indication: Migraine

    Dosage: 20 mg, prn
    Administration route: Oral
    Indication: Migraine
    Start date: 2011-06-01

Other drugs received by patient: Topamax; Lipitor

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017